Curated by Dewpoint Therapeutics
Contribute Contact
search icon
Condensates Logo
  • Condensates 101
    • Introduction to Condensates
    • Key Publications
    • Condensates Glossary
  • Publications & Events
    • Publications
    • Kitchen Table Talks
    • Community Events
  • Resources
    • CD-CODE
    • C-mods
    • Condensatopathies
  • Expert Voice
  • Subscribe for Free
  • Log In
  • My Account
  • Subscribe for Free
  • Log in

Expert Voice

    View Your Favorites

    Access your saved content with one easy click.

    My Favorites

    Save Your Favorites

    Subscribe for free to save your favorites and view a personalized view of content.

    Subscribe for Free

    Be a Contributor

    Submit new content suggestions for Condensates.com.

    Contribute

Home

Condensate News: “Microphases are targets for therapeutic intervention for neurodegenerative disorders”

Topics
  • Biology and Physics of Condensates
  • Cancer
Tags
  • Biomolecular condensates
  • Membraneless organelles
  • Nuclear speckles
  • Phase separation
Share

Our understanding of condensate structure is moving beyond coarse-grained droplet cartoons toward actionable, designable mesoscale structure. A new study from Rohit Pappu’s lab at Washington University at St. Luis marks an exciting inflexion point in the field, where our simplistic understanding of nuclear speckles as liquid droplets is upgraded to a nano-architectured view with therapeutic implications.

Groundbreaking findings show that key speckle proteins, including disease‑relevant factors like TDP‑43, behave as unconventional block copolymers that spontaneously form size‑limited microphases rather than classic liquid-like droplets, neatly explaining the mottled nuclear organization long seen in imaging. By tying these microphases to specific sequence grammars in both proteins and the long non-coding RNA MALAT1, and by introducing the broader conceptual class of “FRODO” molecules as generic organizers of condensates, the work opens an enticing path where one can imagine rationally tuning nanoscale architecture to modulate splicing, ALS‑linked aggregation, and even cancer phenotypes.

Learn more about this topic in this News & views article by Beth Miller.

Image credit: Lamond AI & Spector DL, Nat Rev Mol Cell Biol (2003)

 

 

 

 

 

 

 

 

  • Introduction to Condensates
  • Publications & Events
  • Resources
  • Expert Voice
  • Subscribe
  • Log In
  • My Account
  • Sign Out
  • About Condensates.com
  • About Dewpoint

Contribute

News, events, resources, and insights by and for the condensate community.

Contribute

© 2026 Dewpoint Therapeutics

  • Privacy
  • Terms
wpDiscuz